Literature DB >> 27830780

The road to restoring neural circuits for the treatment of Alzheimer's disease.

Rebecca G Canter1, Jay Penney1, Li-Huei Tsai1,2.   

Abstract

Alzheimer's disease is a progressive loss of memory and cognition, for which there is no cure. Although genetic studies initially suggested a primary role for amyloid-in Alzheimer's disease, treatment strategies targeted at reducing amyloid-have failed to reverse cognitive symptoms. These clinical findings suggest that cognitive decline is the result of a complex pathophysiology and that targeting amyloid-alone may not be sufficient to treat Alzheimer's disease. Instead, a broad outlook on neural-circuit-damaging processes may yield insights into new therapeutic strategies for curing memory loss in the disease.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27830780     DOI: 10.1038/nature20412

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  147 in total

1.  The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.

Authors:  Guy M McKhann; David S Knopman; Howard Chertkow; Bradley T Hyman; Clifford R Jack; Claudia H Kawas; William E Klunk; Walter J Koroshetz; Jennifer J Manly; Richard Mayeux; Richard C Mohs; John C Morris; Martin N Rossor; Philip Scheltens; Maria C Carrillo; Bill Thies; Sandra Weintraub; Creighton H Phelps
Journal:  Alzheimers Dement       Date:  2011-04-21       Impact factor: 21.566

2.  Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides.

Authors:  B A Yankner; L K Duffy; D A Kirschner
Journal:  Science       Date:  1990-10-12       Impact factor: 47.728

3.  Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding.

Authors:  G T Bramblett; M Goedert; R Jakes; S E Merrick; J Q Trojanowski; V M Lee
Journal:  Neuron       Date:  1993-06       Impact factor: 17.173

4.  Phosphorylation affects the ability of tau protein to promote microtubule assembly.

Authors:  G Lindwall; R D Cole
Journal:  J Biol Chem       Date:  1984-04-25       Impact factor: 5.157

5.  Long-term associations between cholinesterase inhibitors and memantine use and health outcomes among patients with Alzheimer's disease.

Authors:  Carolyn W Zhu; Elayne E Livote; Nikolaos Scarmeas; Marilyn Albert; Jason Brandt; Deborah Blacker; Mary Sano; Yaakov Stern
Journal:  Alzheimers Dement       Date:  2013-01-17       Impact factor: 21.566

6.  Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease.

Authors:  P Mecocci; U MacGarvey; M F Beal
Journal:  Ann Neurol       Date:  1994-11       Impact factor: 10.422

7.  Candidate gene for the chromosome 1 familial Alzheimer's disease locus.

Authors:  E Levy-Lahad; W Wasco; P Poorkaj; D M Romano; J Oshima; W H Pettingell; C E Yu; P D Jondro; S D Schmidt; K Wang
Journal:  Science       Date:  1995-08-18       Impact factor: 47.728

8.  Basolateral amygdala bidirectionally modulates stress-induced hippocampal learning and memory deficits through a p25/Cdk5-dependent pathway.

Authors:  Damien Rei; Xenos Mason; Jinsoo Seo; Johannes Gräff; Andrii Rudenko; Jun Wang; Richard Rueda; Sandra Siegert; Sukhee Cho; Rebecca G Canter; Alison E Mungenast; Karl Deisseroth; Li-Huei Tsai
Journal:  Proc Natl Acad Sci U S A       Date:  2015-05-20       Impact factor: 11.205

9.  Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease.

Authors:  J C Lambert; C A Ibrahim-Verbaas; D Harold; A C Naj; R Sims; C Bellenguez; A L DeStafano; J C Bis; G W Beecham; B Grenier-Boley; G Russo; T A Thorton-Wells; N Jones; A V Smith; V Chouraki; C Thomas; M A Ikram; D Zelenika; B N Vardarajan; Y Kamatani; C F Lin; A Gerrish; H Schmidt; B Kunkle; M L Dunstan; A Ruiz; M T Bihoreau; S H Choi; C Reitz; F Pasquier; C Cruchaga; D Craig; N Amin; C Berr; O L Lopez; P L De Jager; V Deramecourt; J A Johnston; D Evans; S Lovestone; L Letenneur; F J Morón; D C Rubinsztein; G Eiriksdottir; K Sleegers; A M Goate; N Fiévet; M W Huentelman; M Gill; K Brown; M I Kamboh; L Keller; P Barberger-Gateau; B McGuiness; E B Larson; R Green; A J Myers; C Dufouil; S Todd; D Wallon; S Love; E Rogaeva; J Gallacher; P St George-Hyslop; J Clarimon; A Lleo; A Bayer; D W Tsuang; L Yu; M Tsolaki; P Bossù; G Spalletta; P Proitsi; J Collinge; S Sorbi; F Sanchez-Garcia; N C Fox; J Hardy; M C Deniz Naranjo; P Bosco; R Clarke; C Brayne; D Galimberti; M Mancuso; F Matthews; S Moebus; P Mecocci; M Del Zompo; W Maier; H Hampel; A Pilotto; M Bullido; F Panza; P Caffarra; B Nacmias; J R Gilbert; M Mayhaus; L Lannefelt; H Hakonarson; S Pichler; M M Carrasquillo; M Ingelsson; D Beekly; V Alvarez; F Zou; O Valladares; S G Younkin; E Coto; K L Hamilton-Nelson; W Gu; C Razquin; P Pastor; I Mateo; M J Owen; K M Faber; P V Jonsson; O Combarros; M C O'Donovan; L B Cantwell; H Soininen; D Blacker; S Mead; T H Mosley; D A Bennett; T B Harris; L Fratiglioni; C Holmes; R F de Bruijn; P Passmore; T J Montine; K Bettens; J I Rotter; A Brice; K Morgan; T M Foroud; W A Kukull; D Hannequin; J F Powell; M A Nalls; K Ritchie; K L Lunetta; J S Kauwe; E Boerwinkle; M Riemenschneider; M Boada; M Hiltuenen; E R Martin; R Schmidt; D Rujescu; L S Wang; J F Dartigues; R Mayeux; C Tzourio; A Hofman; M M Nöthen; C Graff; B M Psaty; L Jones; J L Haines; P A Holmans; M Lathrop; M A Pericak-Vance; L J Launer; L A Farrer; C M van Duijn; C Van Broeckhoven; V Moskvina; S Seshadri; J Williams; G D Schellenberg; P Amouyel
Journal:  Nat Genet       Date:  2013-10-27       Impact factor: 38.330

10.  Tau promotes neurodegeneration through global chromatin relaxation.

Authors:  Bess Frost; Martin Hemberg; Jada Lewis; Mel B Feany
Journal:  Nat Neurosci       Date:  2014-01-26       Impact factor: 24.884

View more
  153 in total

1.  Upregulation of Alzheimer's Disease Amyloid-β Protein Precursor in Astrocytes Both in vitro and in vivo.

Authors:  Yingxia Liang; Frank Raven; Joseph F Ward; Sherri Zhen; Siyi Zhang; Haoqi Sun; Sean J Miller; Se Hoon Choi; Rudolph E Tanzi; Can Zhang
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

2.  Formaldehyde, Epigenetics, and Alzheimer's Disease.

Authors:  Fei Wang; Danqi Chen; Peipei Wu; Catherine Klein; Chunyuan Jin
Journal:  Chem Res Toxicol       Date:  2019-04-19       Impact factor: 3.739

3.  Gamma frequency entrainment attenuates amyloid load and modifies microglia.

Authors:  Hannah F Iaccarino; Annabelle C Singer; Anthony J Martorell; Andrii Rudenko; Fan Gao; Tyler Z Gillingham; Hansruedi Mathys; Jinsoo Seo; Oleg Kritskiy; Fatema Abdurrob; Chinnakkaruppan Adaikkan; Rebecca G Canter; Richard Rueda; Emery N Brown; Edward S Boyden; Li-Huei Tsai
Journal:  Nature       Date:  2016-12-07       Impact factor: 49.962

4.  Stability analysis of a steady state of a model describing Alzheimer's disease and interactions with prion proteins.

Authors:  Mohammed Helal; Angélique Igel-Egalon; Abdelkader Lakmeche; Pauline Mazzocco; Angélique Perrillat-Mercerot; Laurent Pujo-Menjouet; Human Rezaei; Léon M Tine
Journal:  J Math Biol       Date:  2018-08-11       Impact factor: 2.259

5.  Enriched physical environment reverses spatial cognitive impairment of socially isolated APPswe/PS1dE9 transgenic mice before amyloidosis onset.

Authors:  Min Cao; Pan-Pan Hu; Yan-Li Zhang; Yi-Xin Yan; Christopher B Shields; Yi-Ping Zhang; Gang Hu; Ming Xiao
Journal:  CNS Neurosci Ther       Date:  2017-12-23       Impact factor: 5.243

Review 6.  Neurophysiological markers of network dysfunction in neurodegenerative diseases.

Authors:  Roisin McMackin; Peter Bede; Niall Pender; Orla Hardiman; Bahman Nasseroleslami
Journal:  Neuroimage Clin       Date:  2019-02-02       Impact factor: 4.881

7.  Epigallocatechin-3-gallate Alleviates Cognitive Deficits in APP/PS1 Mice.

Authors:  Jian Bao; Wei Liu; Hong-Yan Zhou; Yu-Ran Gui; You-Hua Yang; Meng-Juan Wu; Yi-Fan Xiao; Jin-Ting Shang; Gui-Feng Long; Xi-Ji Shu
Journal:  Curr Med Sci       Date:  2020-03-13

8.  L-3-n-Butylphthalide Effectively Improves the Glymphatic Clearance and Reduce Amyloid-β Deposition in Alzheimer's Transgenic Mice.

Authors:  Bo Zhang; Wei Li; Youguang Zhuo; Hui Xiang; Wenfeng Li; Hongying Liu; Longchang Xie; Qingchun Gao; Sheng Tan
Journal:  J Mol Neurosci       Date:  2020-11-13       Impact factor: 3.444

Review 9.  A Scoping Review of Neuromodulation Techniques in Neurodegenerative Diseases: A Useful Tool for Clinical Practice?

Authors:  Fabio Marson; Stefano Lasaponara; Marco Cavallo
Journal:  Medicina (Kaunas)       Date:  2021-02-27       Impact factor: 2.430

10.  Improved Scalability of Neuron-Based Phenotypic Screening Assays for Therapeutic Discovery in Neuropsychiatric Disorders.

Authors:  Timothy P Spicer; Christopher Hubbs; Thomas Vaissiere; Deanna Collia; Camilo Rojas; Murat Kilinc; Kyle Vick; Franck Madoux; Pierre Baillargeon; Justin Shumate; Kirill A Martemyanov; Damon T Page; Sathya Puthanveettil; Peter Hodder; Ronald Davis; Courtney A Miller; Louis Scampavia; Gavin Rumbaugh
Journal:  Mol Neuropsychiatry       Date:  2017-11-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.